Pharmacist, Owner John Herr and Director of Pharmacy Operations, Viral Jani, PharmD have completed training in Good Clinical Practices.
National Institute of Health (NIH) expects all NIH-funded clinical investigators and clinical trial staff who are involved in the design, conduct, oversight, or management of clinical trials to be trained in Good Clinical Practice (GCP). Recipients of GCP training are expected to retain documentation of their training.
GCP training should be refreshed at least every three years in order to stay up to date with regulations, standards, and guidelines.
Pharmacist Owner John Herr and Director of Pharmacy Operations, Viral Jani, PharmD have completed training in Good Clinical Practices.
Purpose
The principles of Good Clinical Practice (GCP) help assure the safety, integrity, and quality of clinical trials by addressing elements related to the design, conduct, and reporting of clinical trials. GCP training describes the responsibilities of investigators, sponsors, monitors, and IRBs in the conduct of clinical trials.
GCP training aims to ensure that:
- the rights, safety, and well-being of human subjects are protected
- clinical trials are conducted in accordance with approved plans with rigor and integrity
- data derived from clinical trials are reliable
Source: NIH
Owner/Pharmacist John Herr recently attended the APC meeting in La Jolla, CA, and was part of a panel discussing pharmacy compounding and clinical trials. He explains the importance of GCP certification.
Need Clinical Trials? Let's Get Started.
Whether you require ten doses or thousands of doses for your R&D or clinical trial phase, Town & Country Compounding can deliver! We take pride in working with your team from initial development of the study or trial and through all aspects of the study or trial up until completion.
